作者:B. Strydom、J. Bergh、J. Petzer
DOI:10.1055/s-0032-1323662
日期:——
Previous studies have documented that substituted 8-oxycaffeines act as inhibitors of human monoamine oxidase (MAO) B. A particularly potent inhibitor among the reported compounds was 8-(2-phenoxyethoxy)caffeine with an IC50 value of 0.383 µM towards MAO-B. In an attempt to improve on the inhibition potency of this compound and to discover highly potent reversible MAO-B inhibitors, in the present study, a series of 8-(2-phenoxyethoxy)caffeine analogues containing various substituents on C4 of the phenoxy ring, were synthesized and evaluated as inhibitors of human MAO-A and -B. The results show that the 8-(2-phenoxyethoxy)caffeine analogues are selective and reversible MAO-B inhibitors with the most potent homologue, 8-2-[4-(trifluoromethyl)phenoxy]ethoxy}caffeine, exhibiting an IC50 value of 0.061 μM. These highly potent inhibitors are useful leads in the design of therapies for neurodegenerative disorders such as Parkinson’s disease.
在已报道的化合物中,8-(2-苯氧基乙氧基)咖啡因是一种特别有效的抑制剂,其对 MAO-B 的 IC50 值为 0.383 µM。为了提高该化合物的抑制效力并发现高效的可逆 MAO-B 抑制剂,本研究合成了一系列 8-(2-苯氧基乙氧基)咖啡因类似物,这些类似物在苯氧基环的 C4 上含有不同的取代基,并将其作为人类 MAO-A 和 MAO-B 的抑制剂进行了评估。结果表明,8-(2-苯氧基乙氧基)咖啡因类似物是选择性和可逆的 MAO-B 抑制剂,其中最强的同系物 8-2-[4-(三氟甲基)苯氧基]乙氧基}咖啡因的 IC50 值为 0.061 μM。这些强效抑制剂是设计帕金森病等神经退行性疾病疗法的有用线索。